Business Description
Sinovac Biotech Ltd
NAICS : 325412
SIC : 2834
ISIN : AGP8696W1045
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 32.59 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -15.81 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.83 | |||||
Beneish M-Score | -2.2 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.1 | |||||
3-Year Book Growth Rate | 152.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 11.39 | |||||
Quick Ratio | 11.24 | |||||
Cash Ratio | 10.81 | |||||
Days Inventory | 1706.67 | |||||
Days Sales Outstanding | 346.24 | |||||
Days Payable | 5299.24 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 10.2 | |||||
Shareholder Yield % | -31.03 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 92.09 | |||||
Operating Margin % | -84.35 | |||||
Net Margin % | -29.06 | |||||
FCF Margin % | -94.31 | |||||
ROE % | -1.44 | |||||
ROA % | -0.93 | |||||
ROIC % | -34.45 | |||||
3-Year ROIIC % | -91.56 | |||||
ROC (Joel Greenblatt) % | -14.52 | |||||
ROCE % | -1.22 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 0.83 | |||||
Price-to-Owner-Earnings | 5.43 | |||||
PS Ratio | 1.5 | |||||
PB Ratio | 0.05 | |||||
Price-to-Tangible-Book | 0.05 | |||||
EV-to-EBIT | 46.07 | |||||
EV-to-EBITDA | 337.72 | |||||
EV-to-Revenue | -16.15 | |||||
EV-to-FCF | 17.12 | |||||
Price-to-Projected-FCF | 0.02 | |||||
Price-to-Median-PS-Value | 0.5 | |||||
Price-to-Net-Current-Asset-Value | 0.07 | |||||
Price-to-Net-Cash | 0.07 | |||||
Earnings Yield (Greenblatt) % | 2.17 | |||||
FCF Yield % | -87.95 | |||||
Forward Rate of Return (Yacktman) % | 335.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sinovac Biotech Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 429.204 | ||
EPS (TTM) ($) | -1.31 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 6.47 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 6.47 - 6.47 | ||
Shares Outstanding (Mil) | 71.86 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sinovac Biotech Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sinovac Biotech Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Sinovac Biotech Ltd Frequently Asked Questions
What is Sinovac Biotech Ltd(SVA)'s stock price today?
When is next earnings date of Sinovac Biotech Ltd(SVA)?
Does Sinovac Biotech Ltd(SVA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |